CLYM — CLIMB BIO INC
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR
As of Q2 2026, 114 SEC-registered investment managers reported holding CLYM (CLIMB BIO INC) in their latest 13F filings, with a combined reported value of $751.72M across 59.79M shares. That is +56.8% by share count (+16.27M shares) versus the previous quarter, while reported value moved +204.7%. Ownership is concentrated: the five largest holders account for 46.5% of reported value and the top ten for 64.2%.
Compared with the prior quarter, 55 opened new positions, 33 added to existing stakes, 19 trimmed, 24 exited entirely. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q2 2026, not real-time trading.
Major shareholders of CLIMB BIO INC (CLYM) include RA CAPITAL MANAGEMENT, L.P., Fidelity Management & Research (FMR), UBS Group AG, ranked by reported 13F value among the 211 institutional holders on this page.
CLYM is classified in the Health Care sector.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
Institutional Ownership by Quarter
| Quarter | Funds holding | Shares | Value | QoQ Net Change |
|---|---|---|---|---|
| Q3 2026 | 80 | 29.90M | $343.01M | +39.5% |
| Q2 2026 | 114 | 59.79M | $751.72M | +56.8% |
| Q1 2026 | 83 | 35.04M | $226.92M | -3.5% |
| Q4 2025 | 65 | 33.04M | $157.04M | -36.6% |
| Q3 2025 | 67 | 45.59M | $90.57M | -10.1% |
| Q2 2025 | 69 | 50.87M | $62.41M | -2.7% |
| Q1 2025 | 78 | 52.43M | $63.26M | +3.0% |
| Q4 2024 | 78 | 56.14M | $99.93M | +0.0% |
Over the 8 quarters shown, institutional share counts decreased 47% in aggregate (Q4 2024 → Q3 2026); the largest single-quarter swing was Q2 2026 (+56.8%).
Top Institutional Holders (Q3 2026) — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 9.27M | $106.32M | 0.01% | Add | |
| 4.49M | $51.49M | 0.02% | Add | |
| 2.94M | $33.69M | 0.00% | Add | |
| 2.38M | $27.25M | 0.00% | Add | |
| 1.85M | $21.22M | 0.00% | Add | |
| 1.12M | $12.85M | 0.00% | Add | |
| 972.00K | $11.15M | 0.52% | Hold | |
| 951.06K | $10.91M | 0.00% | Add | |
| 730.00K | $8.37M | 0.12% | New | |
| 558.52K | $6.41M | 0.01% | New | |
| 501.20K | $5.75M | 0.00% | Add | |
| 401.55K | $4.61M | 0.00% | Add | |
| 360.65K | $4.14M | 0.40% | Hold | |
| 303.70K | $3.49M | 0.00% | Add | |
| 290.85K | $3.34M | 0.06% | New | |
| 287.30K | $3.30M | 0.00% | Add | |
| 254.11K | $2.91M | 0.01% | Add | |
| 181.51K | $2.08M | 0.00% | Add | |
| 181.46K | $2.08M | 0.00% | Add | |
| 157.20K | $1.80M | 0.00% | Add | |
| 135.01K | $1.55M | 0.00% | Add | |
| 132.90K | $1.52M | 0.33% | Add | |
| 130.18K | $1.49M | 0.00% | Add | |
| 102.95K | $1.18M | 0.00% | Reduce | |
| 86.55K | $992.76K | 0.00% | Add |
Holder history for earlier quarters, one table per quarter: Back to the Top 25 holders
Q2 2026 — 25 funds
Q1 2026 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 11.30M | $77.41M | 0.82% | Hold | |
| 2.59M | $17.77M | 1.37% | Reduce | |
| 1.92M | $13.13M | 0.00% | Hold | |
| 1.53M | $10.48M | 0.40% | New | |
| 1.33M | $9.14M | 2.10% | Add | |
| 1.28M | $8.74M | 0.00% | Add | |
| 1.28M | $8.74M | 0.01% | Add | |
| 1.18M | $8.07M | 0.00% | New | |
| 1.00M | $6.87M | 0.44% | Reduce | |
| 773.12K | $5.30M | 0.01% | Add | |
| 700.00K | $4.79M | 0.26% | Reduce | |
| 684.91K | $4.69M | 0.58% | New | |
| 600.95K | $4.12M | 0.03% | Hold | |
| 597.66K | $4.09M | 0.28% | Reduce | |
| 420.52K | $2.88M | 0.32% | Reduce | |
| 419.25K | $2.87M | 0.47% | Reduce | |
| 401.65K | $2.75M | 0.00% | Add | |
| 345.66K | $2.37M | 0.00% | Add | |
| 313.00K | $2.15M | 0.00% | Add | |
| 310.61K | $2.13M | 0.00% | Reduce | |
| 286.13K | $1.96M | 0.69% | New | |
| 250.10K | $1.71M | 0.00% | Add | |
| 234.18K | $1.60M | 0.00% | Add | |
| 217.77K | $1.49M | 0.07% | New | |
| 217.30K | $1.49M | 0.00% | Reduce |
Q4 2025 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 11.29M | $77.71M | 0.80% | Reduce | |
| 2.67M | $10.69M | 1.22% | New | |
| 1.92M | $7.70M | 0.00% | Add | |
| 1.43M | $5.73M | 0.45% | Add | |
| 1.34M | $5.36M | 0.00% | Add | |
| 1.30M | $5.20M | 0.32% | Hold | |
| 1.03M | $4.11M | 0.28% | Hold | |
| 979.53K | $3.92M | 1.27% | New | |
| 932.25K | $3.73M | 0.74% | Add | |
| 716.68K | $2.87M | 0.01% | New | |
| 600.95K | $2.40M | 0.02% | New | |
| 566.71K | $2.27M | 0.01% | Add | |
| 565.99K | $2.26M | 1.93% | Add | |
| 463.65K | $1.85M | 0.15% | Hold | |
| 445.34K | $1.78M | 0.00% | Add | |
| 389.31K | $1.56M | 0.00% | Reduce | |
| 320.60K | $1.28M | 0.00% | Reduce | |
| 310.76K | $1.24M | 0.00% | Hold | |
| 304.01K | $1.22M | 0.00% | Add | |
| 296.31K | $1.19M | 0.00% | Reduce | |
| 296.31K | $1.19M | 0.00% | Reduce | |
| 246.20K | $984.80K | 0.00% | Add | |
| 239.04K | $956.17K | 0.00% | New | |
| 224.88K | $899.53K | 0.00% | Add | |
| 201.65K | $806.61K | 0.04% | New |
Q3 2025 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 31.42M | $63.15M | 0.78% | Hold | |
| 1.32M | $2.64M | 0.00% | Reduce | |
| 1.30M | $2.61M | 0.25% | Reduce | |
| 1.03M | $2.07M | 0.15% | Hold | |
| 1.00M | $2.01M | 0.08% | Hold | |
| 735.50K | $1.48M | 0.00% | Reduce | |
| 561.87K | $1.13M | 1.01% | Add | |
| 547.17K | $1.10M | 0.04% | Reduce | |
| 537.10K | $1.08M | 0.00% | Add | |
| 526.92K | $1.06M | 0.00% | Reduce | |
| 509.79K | $1.02M | 0.03% | Reduce | |
| 485.36K | $975.58K | 0.00% | Hold | |
| 471.70K | $948.12K | 0.00% | Reduce | |
| 471.70K | $948.12K | 0.00% | Reduce | |
| 463.65K | $931.95K | 0.09% | Hold | |
| 434.84K | $874.02K | 0.20% | Add | |
| 405.40K | $814.86K | 0.00% | Add | |
| 329.55K | $662.39K | 0.00% | Reduce | |
| 311.72K | $626.87K | 0.00% | Hold | |
| 229.89K | $462.08K | 0.00% | Add | |
| 150.00K | $301.50K | 0.05% | Reduce | |
| 142.45K | $286.32K | 0.00% | Add | |
| 136.49K | $274.34K | 0.10% | Reduce | |
| 133.53K | $268.39K | 0.03% | Add | |
| 125.42K | $252.10K | 0.00% | Reduce |
Q2 2025 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 31.42M | $38.96M | 0.66% | Hold | |
| 2.50M | $3.10M | 0.19% | Add | |
| 1.61M | $2.00M | 0.00% | Reduce | |
| 1.50M | $1.86M | 0.29% | Hold | |
| 1.33M | $1.65M | 0.00% | Reduce | |
| 1.04M | $1.29M | 0.04% | Hold | |
| 1.03M | $1.28M | 0.14% | Reduce | |
| 1.00M | $1.24M | 0.06% | Hold | |
| 877.97K | $1.09M | 0.00% | Reduce | |
| 702.13K | $870.65K | 0.39% | Add | |
| 555.67K | $689.02K | 0.69% | Hold | |
| 547.97K | $680.00K | 0.00% | Reduce | |
| 495.50K | $614.42K | 0.00% | Reduce | |
| 485.36K | $601.85K | 0.00% | New | |
| 480.08K | $595.30K | 0.00% | Add | |
| 480.08K | $595.30K | 0.00% | Add | |
| 463.65K | $574.93K | 0.07% | New | |
| 415.00K | $514.60K | 0.11% | Add | |
| 382.48K | $474.28K | 0.00% | Hold | |
| 311.72K | $386.71K | 0.00% | Reduce | |
| 210.12K | $260.55K | 0.00% | Reduce | |
| 209.84K | $260.20K | 0.07% | Reduce | |
| 201.31K | $249.63K | 0.00% | Add | |
| 179.59K | $222.69K | 0.00% | Reduce | |
| 148.18K | $183.74K | 0.00% | New |
New Positions (Q2 2026)
- ADAGE CAPITAL PARTNERS GP, L.L.C. 2.51M sh · $32.68M
- Cormorant Asset Management, LP 2.11M sh · $27.46M
- FRONTIER CAPITAL MANAGEMENT CO LLC 1.94M sh · $25.28M
- Woodline Partners LP 1.58M sh · $20.63M
- Redmile Group, LLC 1.23M sh · $15.99M
- GEODE CAPITAL MANAGEMENT, LLC 782.20K sh · $10.20M
- STEMPOINT CAPITAL LP 742.75K sh · $9.69M
- AMERIPRISE FINANCIAL INC 657.97K sh · $8.58M
- Parkman Healthcare Partners LLC 563.48K sh · $7.35M
- Invesco Ltd 373.44K sh · $4.87M
- Ikarian Capital, LLC 300.00K sh · $3.91M
- Ally Bridge Group (NY) LLC 249.17K sh · $3.25M
Fully Exited (vs previous quarter)
- MPM BioImpact LLC sold 2.59M sh · $17.77M
- Kynam Capital Management, LP sold 1.00M sh · $6.87M
- Marshall Wace sold 773.12K sh · $5.30M
- SILVERARC CAPITAL MANAGEMENT, LLC sold 684.91K sh · $4.69M
- DIADEMA PARTNERS LP sold 286.13K sh · $1.96M
- Longaeva Partners L.P. sold 217.77K sh · $1.49M
- STATE STREET CORP sold 132.00K sh · $904.20K
- Seven Fleet Capital Management LP sold 130.65K sh · $894.98K
- Peapod Lane Capital LLC sold 108.88K sh · $739.80K
- 683 Capital Management, LLC sold 90.00K sh · $616.50K
- Persistent Asset Partners Ltd sold 72.33K sh · $495.43K
- Point72 Asset Management sold 59.09K sh · $404.77K
Fund Position History — shares by quarter (top 20 funds)
| Fund | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Fidelity Management & Research (FMR) | 9.27M | 6.79M | 6.40K | 6.35K | 7.14K | 7.63K | 2.65K | 13.56K | 16 | — | — | — | — | — | — | — | — | 9 | 94 | — |
| UBS Group AG | 4.49M | 3.40M | 85.94K | 71.32K | 405.40K | 382.48K | 382.23K | 415.36K | 16.25K | 2.22K | 5.92K | — | 89 | — | — | — | — | 2.28K | 1.62K | 4.44K |
| BlackRock Inc | 2.94M | 2.35M | 401.65K | 389.31K | 735.50K | 877.97K | 2.30M | 2.31M | 1.87M | — | — | — | — | — | — | — | — | — | — | — |
| VANGUARD CAPITAL MANAGEMENT LLC | 2.38M | 1.70M | 1.18M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| STATE STREET CORP | 1.85M | — | 132.00K | 128.90K | 103.10K | 103.10K | 378.54K | 378.54K | 315.04K | 59.01K | 21.70K | 21.70K | 21.70K | — | — | — | — | — | — | — |
| Morgan Stanley | 1.12M | 365.09K | 234.18K | 148.54K | 86.33K | 99.46K | 176.98K | 226.85K | 78.18K | 9.88K | 1.71K | 1.71K | 1.71K | 1.71K | 62.32K | 145 | 4.77K | 6.63K | 5.68K | 10.12K |
| Affinity Asset Advisors, LLC | 972.00K | 972.00K | 700.00K | 1.30M | 1.30M | 1.50M | 1.50M | 500.00K | 1.50M | 1.67M | — | — | — | — | — | — | — | — | — | — |
| Geode Capital Management | 951.06K | 782.20K | 313.00K | 310.76K | 311.72K | 311.72K | 673.81K | 660.83K | 651.30K | 171.60K | 66.63K | 66.63K | 66.63K | 64.01K | 64.01K | 64.01K | 64.14K | 64.14K | 113.02K | 115.67K |
| EVENTIDE ASSET MANAGEMENT, LLC | 730.00K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Marshall Wace | 558.52K | — | 773.12K | 304.01K | 229.89K | 36.74K | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 501.20K | 239.66K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| DIMENSIONAL FUND ADVISORS LP | 401.55K | 239.45K | 104.44K | — | — | — | — | — | 18.28K | 12.56K | — | — | — | — | — | — | — | — | — | — |
| NAN FUNG TRINITY (HK) Ltd | 360.65K | 360.65K | 420.52K | 463.65K | 463.65K | 463.65K | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| TD ASSET MANAGEMENT INC | 303.70K | 267.10K | 250.10K | 246.20K | 89.40K | 89.40K | 89.40K | 89.40K | 89.40K | — | — | — | — | — | — | — | — | — | — | — |
| Jefferies Financial Group Inc. | 290.85K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| VANGUARD FIDUCIARY TRUST CO | 287.30K | 195.04K | 158.66K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Squarepoint Ops LLC | 254.11K | 25.96K | 42.97K | — | 17.70K | 19.64K | — | 30.84K | — | — | — | — | — | — | — | — | — | — | — | — |
| FIFTH THIRD BANCORP | 181.51K | 164.92K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Manulife Financial | 181.46K | 164.71K | 156.32K | 140.62K | 38.90K | 38.90K | 40.12K | 38.90K | 49.52K | — | — | — | — | — | — | — | — | — | — | — |
| LPL Financial LLC | 157.20K | 51.17K | 60.38K | 62.00K | 61.00K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
▲ Bought Low (fund opened/added, stock rose ≥5% next quarter) ▼ Sold High (fund reduced, stock fell ≥5% next quarter)
Drag / scroll to zoom · Default shows the most recent year · Annotations come from quarterly fund actions in 13F filings · Hover a marker for details
FAQ
Which funds hold CLYM?
As of 2026-Q2, 114 institutional funds reported holding CLYM (CLIMB BIO INC) in SEC 13F filings, with a combined reported value of $751.72M.
How many shares of CLYM do institutions own?
13F filers reported 59.79M shares of CLYM, worth $751.72M in aggregate at the end of 2026-Q2.
Is institutional ownership of CLYM rising or falling?
Share counts moved +56.8% versus the prior quarter — accumulation.
Who are the top institutional holders of CLYM?
The largest 13F holders are RA CAPITAL MANAGEMENT, L.P., Fidelity Management & Research (FMR), UBS Group AG, BRAIDWELL LP, BlackRock Inc; the top 25 are ranked at the top of this page.
Who are the major shareholders of CLIMB BIO INC?
The major shareholders of CLIMB BIO INC (CLYM) by reported 13F value are RA CAPITAL MANAGEMENT, L.P., Fidelity Management & Research (FMR), UBS Group AG, BRAIDWELL LP, BlackRock Inc, among 211 institutional holders.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.